333 related articles for article (PubMed ID: 6692471)
21. Anchorage-independent growth of v-myc-transformed Balb/c 3T3 cells is promoted by platelet-derived growth factor or co-transformation by other oncogenes.
Vennström B; Bravo R
Oncogene; 1987; 1(3):271-6. PubMed ID: 3330775
[TBL] [Abstract][Full Text] [Related]
22. Enhanced expression and state of the c-myc oncogene in chemically and X-ray-transformed C3H/10T1/2 Cl 8 mouse embryo fibroblasts.
Billings PC; Shuin T; Lillehaug J; Miura T; Roy-Burman P; Landolph JR
Cancer Res; 1987 Jul; 47(14):3643-9. PubMed ID: 2439194
[TBL] [Abstract][Full Text] [Related]
23. Depletion of c-myc with specific antisense sequences reverses the transformed phenotype in ras oncogene-transformed NIH 3T3 cells.
Sklar MD; Thompson E; Welsh MJ; Liebert M; Harney J; Grossman HB; Smith M; Prochownik EV
Mol Cell Biol; 1991 Jul; 11(7):3699-710. PubMed ID: 2046673
[TBL] [Abstract][Full Text] [Related]
24. Constitutive c-myc expression enhances proliferation of differentiating F9 teratocarcinoma cells.
Schulz WA; Gais G
Biochim Biophys Acta; 1989 Sep; 1013(2):125-32. PubMed ID: 2475175
[TBL] [Abstract][Full Text] [Related]
25. N-myc and c-src genes are differentially regulated in PCC7 embryonal carcinoma cells undergoing neuronal differentiation.
Sejersen T; Björklund H; Sümegi J; Ringertz NR
J Cell Physiol; 1986 May; 127(2):274-80. PubMed ID: 3700483
[TBL] [Abstract][Full Text] [Related]
26. Ras proteins are essential and selective for the action of insulin-like growth factor 1 late in the G1 phase of the cell cycle in BALB/c murine fibroblasts.
Lu K; Campisi J
Proc Natl Acad Sci U S A; 1992 May; 89(9):3889-93. PubMed ID: 1570309
[TBL] [Abstract][Full Text] [Related]
27. Glucocorticoid modulation of transformed cell proliferation is oncogene specific and correlates with effects on c-myc levels.
O'Banion MK; Levenson RM; Brinckmann UG; Young DA
Mol Endocrinol; 1992 Sep; 6(9):1371-80. PubMed ID: 1331773
[TBL] [Abstract][Full Text] [Related]
28. Enhanced expression of c-myc and decreased expression of c-fos protooncogenes in chemically and radiation-transformed C3H/10T1/2 Cl 8 mouse embryo cell lines.
Shuin T; Billings PC; Lillehaug JR; Patierno SR; Roy-Burman P; Landolph JR
Cancer Res; 1986 Oct; 46(10):5302-11. PubMed ID: 2875790
[TBL] [Abstract][Full Text] [Related]
29. Oncogene expression in murine splenic T cells and in murine T-cell neoplasms.
Mally MI; Vogt M; Swift SE; Haas M
Virology; 1985 Jul; 144(1):115-26. PubMed ID: 2414915
[TBL] [Abstract][Full Text] [Related]
30. N-myc proto-oncogene expression can induce DNA replication in Balb/c 3T3 fibroblasts.
Cavalieri F; Goldfarb M
Oncogene; 1988 Mar; 2(3):289-91. PubMed ID: 3281096
[TBL] [Abstract][Full Text] [Related]
31. c-myc mRNA levels in the cell cycle change in mouse erythroleukemia cells following inducer treatment.
Lachman HM; Hatton KS; Skoultchi AI; Schildkraut CL
Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5323-7. PubMed ID: 3860863
[TBL] [Abstract][Full Text] [Related]
32. Immortalization and neoplastic transformation of fetal rat intestinal epithelial cells: morphological and cytogenetic analysis, (proto)oncogene expression and effect of gamma-interferon on cell growth.
Emami S; Chastre E; Nizard S; Di Gioia Y; Barbu V; Taillemite JL; Ito S; Gespach C
Digestion; 1990; 46 Suppl 2():74-91. PubMed ID: 2148162
[TBL] [Abstract][Full Text] [Related]
33. Amplification and rearrangement of the Kirsten ras oncogene in virus-transformed BALB/c 3T3 cells during malignant tumor progression.
Radinsky R; Kraemer PM; Raines MA; Kung HJ; Culp LA
Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5143-7. PubMed ID: 3474646
[TBL] [Abstract][Full Text] [Related]
34. Exogenous c-myc gene overexpression interferes with early events in F9 cell differentiation.
Onclercq R; Babinet C; Cremisi C
Oncogene Res; 1989; 4(4):293-302. PubMed ID: 2671866
[TBL] [Abstract][Full Text] [Related]
35. Oncogenes with potential nuclear function: myc, myb and fos.
Eisenman RN; Thompson CB
Cancer Surv; 1986; 5(2):309-27. PubMed ID: 3779660
[TBL] [Abstract][Full Text] [Related]
36. Density-dependent arrest of DNA replication is accompanied by decreased levels of c-myc mRNA in myogenic but not in differentiation-defective myoblasts.
Sejersen T; Sümegi J; Ringertz NR
J Cell Physiol; 1985 Dec; 125(3):465-70. PubMed ID: 4066768
[TBL] [Abstract][Full Text] [Related]
37. Tumor progression following transformation of murine monocytes by v-myc: acquisition of immortalization and tumorigenicity.
Stapleton P; Takayama Y; Hartshorn A; Kalaizis A; Rowe PB; Symonds G
Oncogene; 1991 May; 6(5):807-17. PubMed ID: 1711191
[TBL] [Abstract][Full Text] [Related]
38. Consequences of altered oncogene expression in rodent cells.
Pragnell IB; Spandidos DA; Wilkie NM
Proc R Soc Lond B Biol Sci; 1985 Oct; 226(1242):107-19. PubMed ID: 2866518
[TBL] [Abstract][Full Text] [Related]
39. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
Liebermann DA; Hoffman B
Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
[TBL] [Abstract][Full Text] [Related]
40. Oncogene-mediated transformation of fetal rat colon in vitro.
Pories S; Jaros K; Steele G; Pauley A; Summerhayes IC
Oncogene; 1992 May; 7(5):885-93. PubMed ID: 1373876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
